Scientific Thinking — Biology & Life Sciencev1.0.0

A biotech company identifies a GWAS locus associated with autoimmune disease. Using this skill, the agent evaluates whether the lead variant is a causal driver or merely a passenger variant, assesses linkage disequilibrium, and suggests follow-up functional validation experiments.

A researcher plans a genome-wide CRISPR knockout screen to identify genes essential for cancer cell proliferation. The agent critiques the choice of cell line, controls, and statistical methods, and advises on distinguishing on-target from off-target effects.

A team generates single-cell transcriptomics data from a mouse model of neurodegeneration. The agent helps interpret cell-type-specific gene expression changes, distinguishes transient states from stable cell identities, and assesses relevance to human disease.

A startup developing a therapeutic for metabolic disease tests it in a mouse model. The agent evaluates the similarity of mouse and human pathways, checks for gene redundancy issues, and recommends additional experiments in human organoids or primary cells.

A paper claims a cytokine drives T cell exhaustion based on correlative bulk RNA-seq from patient samples. The agent uses the framework to separate correlation from causation, suggests genetic perturbation experiments, and highlights potential artifacts from bulk averaging.

Offer a subscription service where pharma companies submit a target hypothesis (e.g., a GWAS hit or differentially expressed gene) and receive an AI-generated analysis of its causal role, experimental validation strategies, and translational risks. Revenue from monthly retainers or per-analysis fees.

Provide on-demand consulting to academic labs and biotech startups for designing rigorous experiments (e.g., CRISPR screens, single-cell studies). The AI reviews proposed plans against biological pitfalls and recommends appropriate controls and sample sizes. Revenue from hourly consulting or project-based contracts.

Integrate this skill as an API endpoint within computational drug discovery pipelines. Customers (CROs, software vendors) pay per API call to automatically analyze and validate biological findings from their own data. Revenue from pay-per-call or volume-based tiers.